Ndahayo Kimberly Anne, Connolly Teresa, Simpson Jennifer R, Baranoff Ashley, Pellinen Jacob
Department of Neurology, University of Colorado School of Medicine, Aurora; and.
University of Colorado College of Nursing, Aurora.
Neurol Clin Pract. 2025 Aug;15(4):e200485. doi: 10.1212/CPJ.0000000000200485. Epub 2025 Jun 4.
Birth complications such as autism and neurodevelopmental disabilities have an increased incidence in women with epilepsy (WWE), associated with the use of antiseizure medications, which can be mitigated with folic acid supplementation. This quality improvement (QI) project aimed to increase folic acid prescription rates from 18% to 50% for WWE between ages 18 and 47 seen at a level 4 epilepsy center.
Data from the electronic health record (EHR) were obtained for women meeting inclusion criteria and were analyzed using descriptive statistics and QI methods. Four Plan-Do-Study-Act cycles were conducted during the intervention phase including provider education, implementation of an EHR screening tool, introducing patient educational flyers into clinic rooms, and reporting provider data to improve awareness of prescribing barriers.
Baseline data were collected from January through June 2022, identifying 1,032 patients meeting inclusion criteria. Interventions began in July 2022 and concluded in March 2023 during which time 1,252 patients met inclusion criteria. Folic acid prescription rates for WWE of childbearing age were increased from a baseline of 17.37% to 35.03%. Folic acid prescribing increased throughout the intervention phases. Improving provider awareness of their own prescribing habits along with educational interventions had the largest impact on increasing prescribing rates. All providers effectively received the initial educational intervention.
This QI study demonstrated that increasing provider education and awareness of current clinical practice guidelines increases folic acid prescribing rates for WWE of childbearing age without negatively affecting clinical workflow. This highlights the importance of provider education and ongoing monitoring of folic acid prescribing rates to improve patient outcomes and identifies a series of interventions that can be replicated in a variety of clinical settings.
癫痫女性(WWE)中自闭症和神经发育障碍等出生并发症的发生率有所增加,这与抗癫痫药物的使用有关,而补充叶酸可减轻此类情况。本质量改进(QI)项目旨在将一家四级癫痫中心18至47岁的WWE患者的叶酸处方率从18%提高到50%。
获取符合纳入标准女性的电子健康记录(EHR)数据,并使用描述性统计和QI方法进行分析。在干预阶段进行了四个计划-实施-研究-改进循环,包括对医疗服务提供者的教育、实施EHR筛查工具、在诊室引入患者教育传单以及报告医疗服务提供者的数据以提高对处方障碍的认识。
2022年1月至6月收集了基线数据,确定1032名患者符合纳入标准。干预于2022年7月开始,2023年3月结束,在此期间有1252名患者符合纳入标准。育龄期WWE患者的叶酸处方率从基线的17.37%提高到了35.03%。在整个干预阶段,叶酸处方量都有所增加。提高医疗服务提供者对自身处方习惯的认识以及教育干预对提高处方率的影响最大。所有医疗服务提供者都有效地接受了初始教育干预。
这项QI研究表明,增加医疗服务提供者教育以及对当前临床实践指南的认识可提高育龄期WWE患者的叶酸处方率,且不会对临床工作流程产生负面影响。这凸显了医疗服务提供者教育以及持续监测叶酸处方率对改善患者结局的重要性,并确定了一系列可在各种临床环境中复制的干预措施。